These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 16225622)
1. Primary cutaneous CD30+ T-cell lymphoproliferative disorder following cardiac transplantation in a 15-year-old boy with Netherton's syndrome. Katugampola RP; Finlay AY; Harper JI; Dojcinov S; Maughan TS Br J Dermatol; 2005 Nov; 153(5):1041-6. PubMed ID: 16225622 [TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546 [TBL] [Abstract][Full Text] [Related]
3. Signet ring cell primary cutaneous CD30+ lymphoproliferative disorder presenting as a monomorphic T-cell posttransplant lymphoproliferative disease. Papalas JA; Kulbacki EL; Park HK; Howell ER Am J Dermatopathol; 2012 Oct; 34(7):e94-6. PubMed ID: 22534639 [TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child. Sebire NJ; Malone M; Ramsay AD Pediatr Dev Pathol; 2004; 7(3):290-3. PubMed ID: 15148593 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Benner MF; Jansen PM; Meijer CJ; Willemze R Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236 [TBL] [Abstract][Full Text] [Related]
7. CD30+ lymphoproliferative disorders of the skin: still an open question. Alaibac M; Zarian H; Russo I; Peserico A G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700 [TBL] [Abstract][Full Text] [Related]